Yoshiiku Kawakami

Yoshiiku Kawakami

UNVERIFIED PROFILE

Are you Yoshiiku Kawakami?   Register this Author

Register author
Yoshiiku Kawakami

Yoshiiku Kawakami

Publications by authors named "Yoshiiku Kawakami"

Are you Yoshiiku Kawakami?   Register this Author

100Publications

2721Reads

39Profile Views

CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.

J Viral Hepat 2018 Dec 29;25(12):1555-1564. Epub 2018 Aug 29.

Department of Gastroenterology and Metabolism, Division of Frontier Medical Science, Programs for Biomedical Research Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jvh.12970DOI Listing
December 2018

Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.

Virology 2018 12 18;525:48-61. Epub 2018 Sep 18.

Department of Gastroenterology and Metabolism, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan; Liver Research Project Center, Hiroshima University, Hiroshima, Japan; Laboratory for Digestive Diseases, RIKEN Center for Integrative Medical Sciences, Hiroshima, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2018.08.020DOI Listing
December 2018

Early experience of seven hepatocellular carcinoma cases treated with regorafenib.

Clin Case Rep 2018 Nov 11;6(11):2217-2223. Epub 2018 Oct 11.

Department of Gastroenterology and Metabolism, Applied Life Sciences Institute of Biomedical & Health Sciences Hiroshima University Hiroshima Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.1791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230610PMC
November 2018

Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice.

Hepatol Res 2018 Sep 27;48(10):814-820. Epub 2018 May 27.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13180DOI Listing
September 2018

Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.

Hepatol Res 2018 Feb 24;48(2):193-204. Epub 2017 Jun 24.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12916DOI Listing
February 2018

Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

J Gastroenterol 2018 Feb 24;53(2):269-280. Epub 2017 Jul 24.

Department of Gastroenterology and Metabolism, Division of Frontier Medical Science, Programs for Biomedical Research Graduate School of Biomedical Science, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-017-1368-4DOI Listing
February 2018

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.

Hepatol Res 2018 Jan 27;48(1):51-58. Epub 2017 Apr 27.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12895DOI Listing
January 2018

The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients.

Antivir Ther 2018 ;23(3):239-248

Department of Gastroenterology and Metabolism, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3196DOI Listing
January 2018

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.

PLoS One 2017 7;12(12):e0187409. Epub 2017 Dec 7.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187409PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720697PMC
January 2018

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.

J Gastroenterol 2017 Dec 5;52(12):1252-1257. Epub 2017 May 5.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-017-1345-yDOI Listing
December 2017

Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia.

Clin J Gastroenterol 2017 Aug 9;10(4):383-387. Epub 2017 Jun 9.

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12328-017-0753-0DOI Listing
August 2017

ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C.

J Gastroenterol 2017 Jun 7;52(6):746-753. Epub 2016 Nov 7.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1279-9DOI Listing
June 2017

Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.

J Gastroenterol 2017 Apr 8;52(4):504-511. Epub 2016 Sep 8.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1255-4DOI Listing
April 2017

Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.

J Med Virol 2017 04 24;89(4):665-671. Epub 2016 Oct 24.

Department of Gastroenterology and, Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.24679DOI Listing
April 2017

Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.

Clin J Gastroenterol 2017 Apr 21;10(2):179-184. Epub 2017 Feb 21.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12328-017-0722-7DOI Listing
April 2017

IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.

Hepatol Res 2017 Mar 21;47(3):E5-E13. Epub 2016 Apr 21.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12715DOI Listing
March 2017

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.

J Gastroenterol 2017 Mar 15;52(3):366-375. Epub 2016 Jul 15.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1240-yDOI Listing
March 2017

The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.

J Gastroenterol 2017 Feb 28;52(2):253-262. Epub 2016 Jun 28.

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1236-7DOI Listing
February 2017

Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma.

J Comput Assist Tomogr 2016 Jul-Aug;40(4):524-30

From the *Department of Gastroenterology and Metabolism, Hiroshima University Hospital; and †Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Institute of Biomedical and Health Sciences, ‡Department of Diagnostic Radiology, Graduate School of Biomedical Sciences, and §Liver Research Project Center, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000405DOI Listing
January 2017

Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases.

Hepatol Res 2016 Dec 30;46(13):1402-1408. Epub 2016 Apr 30.

Department of Medicine and Molecular Science, Division of Frontier Medical Science, and, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12698DOI Listing
December 2016

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.

J Gastroenterol 2016 Nov 4;51(11):1073-1080. Epub 2016 Mar 4.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1189-xDOI Listing
November 2016

Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients.

Hepatol Res 2016 Jul 16;46(8):758-64. Epub 2016 Feb 16.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12621DOI Listing
July 2016

Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report.

Hepatol Res 2016 Jun 2;46(7):707-12. Epub 2015 Nov 2.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12602DOI Listing
June 2016

[Vitamin D supplementation on IFN-based therapy].

Nihon Rinsho 2015 Dec;73 Suppl 9:204-8

View Article

Download full-text PDF

Source
December 2015

Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation.

Hepatol Res 2015 Nov 2;45(11):1047-54. Epub 2014 Dec 2.

Department of Gastroenterology and Metabolism, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12447DOI Listing
November 2015

Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy.

J Med Virol 2015 Nov 16;87(11):1913-20. Epub 2015 Jun 16.

Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.24255DOI Listing
November 2015

Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A.

J Hepatol 2015 Sep 4;63(3):554-63. Epub 2015 Apr 4.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan; Liver Research Project Center, Hiroshima University, Hiroshima, Japan; Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.03.033DOI Listing
September 2015

Differences in serum microRNA profiles in hepatitis B and C virus infection.

J Infect 2015 Mar 5;70(3):273-87. Epub 2014 Nov 5.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan; Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan; Liver Research Project Center, Hiroshima University, Hiroshima, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2014.10.017DOI Listing
March 2015

Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT.

Antivir Ther 2014 5;19(3):277-85. Epub 2013 Nov 5.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://www.intmedpress.com/journals/avt/abstract.cfm?id=2706
Publisher Site
http://dx.doi.org/10.3851/IMP2706DOI Listing
January 2015

Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib.

Hepatol Res 2014 Dec 24;44(13):1320-8. Epub 2014 Apr 24.

Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12307DOI Listing
December 2014

HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study.

PLoS One 2013 20;8(12):e84226. Epub 2013 Dec 20.

Laboratory for Digestive Diseases, Center for Integrative Medical Sciences, RIKEN, Hiroshima, Japan ; Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan ; Liver Research Project Center, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0084226PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871580PMC
October 2014

A case of syndrome of inappropriate secretion of antidiuretic hormone following transarterial embolization with cisplatin.

Nihon Shokakibyo Gakkai Zasshi 2014 Sep;111(9):1805-10

Department of Gastroenterology and Hepatology, Hiroshima University Hospital.

View Article

Download full-text PDF

Source
September 2014

Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.

J Gastroenterol 2013 Jan 28;48(1):1-12. Epub 2012 Nov 28.

Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-012-0714-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698425PMC
January 2013